Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:9:p1
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 9 (pt 1/2)
Character Range: 434892–440467

Schedule 9—Prohibited substances

Note 1: See paragraph 7(b) and subsection 57(2).
Note 2: Trivial or unofficial names are marked *.
ACETORPHINE.
ACETYL‑ALPHA‑METHYLFENTANYL.
ALKOXYAMFETAMINES and substituted alkoxyamfetamines except when separately specified in these Schedules.
ALKOXYPHENYLETHYLAMINES and substituted alkoxyphenylethylamines except when separately specified in these Schedules.
ALKYLTHIOAMFETAMINES and substituted alkylthioamfetamines except when separately specified in these Schedules.
ALLYLPRODINE.
ALPHAMEPRODINE.
ALPHA‑METHYLFENTANYL.
ALPHA‑METHYLTHIOFENTANYL.
ALPHAMETHADOL.
ALPHA‑PYRROLIDINOVALEROPHENONE *(ALPHA‑PVP).
2‑AMINO‑1‑(2,5‑DIMETHOXY‑4‑METHYL)PHENYLPROPANE *(STP or DOM).
5‑(2‑AMINOPROPYL)INDAN and substituted 5‑(2‑aminopropyl)indans except when separately specified in these Schedules.
BENZETHIDINE.
BENZOYLINDOLES except when separately specified in these Schedules.
BENZYLPIPERAZINE *(BZP).
BETACETYLMETHADOL.
BETA‑HYDROXYFENTANYL.
BETA‑HYDROXY‑3‑METHYLFENTANYL.
BETAMEPRODINE.
BETAMETHADOL.
BETAPRODINE.
1‑(8‑BROMOBENZO[1,2‑B;4,5‑B]DIFURAN‑4‑YL)‑2‑AMINOPROPANE *(Bromo‑Dragonfly).
4‑BROMO‑2,5‑DIMETHOXYPHENETHYLAMINE *(BDMPEA).
BUFOTENINE.
BUTONITAZENE.
CANNABIS (including seeds, extracts, resins, and the plant and any part of the plant when packed or prepared), except:

       (a) when separately specified in these Schedules; or

       (b) processed hemp fibre containing 0.1% or less of tetrahydrocannabinols and hemp fibre products manufactured from such fibre; or

       (c) hemp seed oil containing 75 mg/kg or less of cannabidiol and 10 mg/kg or less of tetrahydrocannabinols.
CATHINONES except when separately specified in these Schedules.
CLONAZOLAM.
CLONITAZENE.
COCA LEAF.
CODOXIME.
4‑CYANO‑2‑DIMETHYLAMINO‑4,4'‑DIPHENYLBUTANE.
CYCLOHEXYLPHENOLS except:

       (a) when separately specified in these Schedules; or

       (b) in preparations containing 0.5% or less of cyclohexylphenols.
DESCHLOROETIZOLAM.
DESOMORPHINE.
N,N‑DIALKYLAMINOCYCLOHEXYL ALKYL BENZAMIDES except when separately specified in these Schedules.
N,N‑DIALKYLAMINOCYCLOHEXYLMETHYL ALKYL BENZAMIDES except when separately specified in these Schedules.
DIAMPROMIDE.
DIBENZOPYRANS except when separately specified in these Schedules.
3,4‑DICHLORO‑N‑[(1R,2R)‑2‑(DIMETHYLAMINO)CYCLOHEXYL]‑N‑METHYLBENZAMIDE (U‑47700).
3,4‑DICHLORO‑N‑{[1‑ (DIMETHYLAMINO)CYCLOHEXYL]METHYL}BENZAMIDE *(AH‑7921).
DICLAZEPAM.
DIETHYLTHIAMBUTENE.
N,N‑DIETHYLTRYPTAMINE *(DET).
2,5‑DIHYDRO‑2‑(1‑METHYL‑1‑PHENYLETHYL)‑5‑PENTYL‑1H‑PYRIDO[4,3‑B]INDOL‑1‑ONE (SGT‑151).
DIMENOXADOL.
DIMEPHEPTANOL.
2,5‑DIMETHOXYAMFETAMINE *(DMA).
2,5‑DIMETHOXY‑4‑BROMOAMFETAMINE *(DOB).
2,5‑DIMETHOXY‑4‑ETHYL‑a‑AMFETAMINE *(DOET).
2,5‑DIMETHOXY‑4‑ETHYLTHIOPHENETHYLAMINE *(2C‑T‑2).
2,5‑DIMETHOXY‑4‑IODOPHENETHYLAMINE *(2C‑I).
2,5‑DIMETHOXY‑4‑(N)‑PROPYLTHIOPHENETHYLAMINE *(2C‑T‑7).
3‑(2‑DIMETHYLAMINOETHYL)‑4‑HYDROXYINDOLE *(PSILOCINE or PSILOTSIN).
3‑(1,2‑DIMETHYLHEPTYL)‑1‑HYDROXY‑7,8,9,10‑TETRAHYDRO‑6,6,9‑ TRIMETHYL‑6H‑DIBENZO (b,d) PYRAN *(DMHP).
N, α ‑DIMETHYL‑3,4‑(METHYLENEDIOXY)PHENYLETHYLAMINE *(MDMA) except when included in Schedule 8.
N,N‑DIMETHYLAMFETAMINE (Dimetamfetamine).
DIMETHYLTHIAMBUTENE.
N,N‑DIMETHYLTRYPTAMINE *(DMT).
DIOXAPHETYL BUTYRATE.
DIPHENIDINE.
ECGONINE.
EPHENIDINE.
N‑ETHYL‑α‑METHYL‑3,4‑(METHYLENEDIOXY)PHENETHYLAMINE *(N‑ETHYL MDA).
ETHYLMETHYLTHIAMBUTENE.
ETICYCLIDINE *(PCE).
ETODESNITAZENE.
ETONITAZENE.
ETONITAZEPIPNE.
ETONITAZEPYNE.
ETORPHINE.
ETOXERIDINE.
FENETYLLINE.
4‑FLUORO‑N‑METHYLAMFETAMINE.
FLUBROMAZEPAM.
FLUBROMAZOLAM.
FLUNITAZENE.
1‑(5‑FLUOROPENTYL)‑3‑(2‑IODOBENZOYL)INDOLE *(AM‑694).
FURETHIDINE.
HARMALA ALKALOIDS except in herbs, or preparations, for therapeutic use:

       (a) containing 0.1% or less of harmala alkaloids; or

       (b) in divided preparations containing 2 mg or less of harmala alkaloids per recommended daily dose.
HEROIN.
3‑HEXYL‑1‑HYDROXY‑7,8,9,10‑TETRAHYDRO‑6,6,9‑TRIMETHYL‑6H‑DIBENZO (b,d) PYRAN *(PARAHEXYL).
4‑HYDROXYBUTANOIC ACID and its salts except for sodium oxybate when in Schedule 8. *(GAMMA HYDROXYBUTYRATE (GHB)).
2‑[(1R,3S)‑3‑HYDROXYCYCLOHEXYL]‑5‑(2‑METHYLNONAN‑2‑YL)PHENOL *(Cannabicyclohexanol or CP 47,497 C8 homologue).
2‑[(1R,3S)‑3‑HYDROXYCYCLOHEXYL]‑5‑(2‑METHYLOCTAN‑2‑YL)PHENOL *(CP 47,497).
HYDROXYPETHIDINE.
IBOTENIC ACID.
ISOMETHADONE.
ISOPHENIDINE.
ISOTONITAZENE.
KETOBEMIDONE.
LEVOMETHORPHAN (excluding its stereoisomers).
LEVOPHENACYLMORPHAN.
LYSERGIC ACID.
LYSERGIDE.
MECLONAZEPAM.
MECLOQUALONE.
METAZOCINE.
METHAQUALONE.
METHCATHINONE.
METHOXPHENIDINE.
5‑METHOXY‑ α –METHYLTRYPTAMINE *(5‑MeO‑AMT).
5‑METHOXY‑3,4‑METHYLENEDIOXYAMFETAMINE *(MMDA).
4‑METHOXY‑ α –METHYLPHENYLETHYLAMINE *(PMA).
2‑(2‑METHOXYPHENYL)‑1‑(1‑PENTYLINDOL‑3‑YL)ETHANONE *(JWH‑250).
METHYL (2S, 4aR, 6aR, 7R, 9S, 10aS, 10bR)‑9‑ACETOXY‑6a,10b‑DIMETHYL‑4,10‑DIOXO‑DODECAHYDRO‑2‑(3‑FURYL)‑2H‑NAPHTHO[2,1‑c]PYRAN‑7‑CARBOXYLATE *(SALVINORIN A).
4‑METHYLAMINOREX.
METHYLDESORPHINE.
3,4‑METHYLENEDIOXYAMFETAMINE *(MDA).
3,4‑METHYLENEDIOXYPYROVALERONE *(MDPV).
3‑METHYLFENTANYL.
4‑METHYLMETHCATHINONE *(MEPHEDRONE).
N‑ α ‑[METHYL‑3,4‑(METHYLENEDIOXY)PHENETHYL]HYDROXYLAMINE *(N‑HYDROXY MDA).
N‑METHYL‑1‑(3,4‑METHYLENEDIOXYPHENYL)‑2‑BUTANAMINE *(MBDB).
2‑METHYL‑3‑MORPHOLINO‑1, 1‑DIPHENYLPROPANE CARBOXYLIC ACID (Moramide intermediate).
METHYLONE *(MDMC).
1‑METHYL‑4‑PHENYL‑4‑PIPERIDINOL PROPIONATE *(MPPP).
4‑METHYLTHIOAMFETAMINE.
3‑METHYLTHIOFENTANYL.
METODESNITAZENE.
METONITAZENE.
METOPON.
MITRAGYNA SPECIOSA.
MITRAGYNINE.
MORPHERIDINE.
(1‑(2‑MORPHOLIN‑4‑YLETHYL)INDOL‑3‑YL)‑NAPTHALEN‑1‑YLMETHANONE *(JWH‑200).
MUSCIMOL.